HSPB1 and Alzheimer disease: At the same time HSPB1 can segregate toxic Aβ oligomers and convert them into large non-toxic aggregates to eliminate the toxicity of Aβ oligomers to cells, potentially reducing plaque deposition in AD patients (Ojha et al., 2023).